文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

抑制Syndecan-1脱落通过维持肾小管上皮细胞极性保护肾缺血再灌注损伤

Suppressing Syndecan-1 Shedding to Protect Against Renal Ischemia/Reperfusion Injury by Maintaining Polarity of Tubular Epithelial Cells.
PubMed 文献 · Shock · 2022-01-01
一句话结论肾缺血再灌注时SDC-1脱落增加、细胞极性丧失;抑制SDC-1脱落(GM6001)可恢复极性、减少凋亡并减轻肾损伤。

该研究在小鼠肾缺血再灌注模型、三维肾小管体外模型及心脏术后患者中探讨SDC-1脱落与缺血性急性肾损伤的关系。再灌注12和24小时血清SDC-1脱落水平升高,Na+/K+-ATPase-α1表达下降,伴细胞极性丧失和凋亡增加。用GM6001抑制SDC-1脱落后,SDC-1与Na+/K+-ATPase-α1表达恢复、凋亡减少,GM6001预处理可减轻小鼠缺血再灌注损伤。心脏术后患者血浆SDC-1在AKI组显著高于非AKI组,预测AKI的ROC曲线下面积为0.769。

要点

  • 肾缺血再灌注后血清SDC-1脱落水平在再灌注12和24小时升高,同时Na+/K+-ATPase-α1表达下降、肾小管上皮细胞极性丧失。
  • 体外三维肾小管模型缺氧/复氧后SDC-1脱落增加、Na+/K+-ATPase-α1减少、凋亡增加,且随缺氧时间延长而加重。
  • GM6001抑制SDC-1脱落后,SDC-1和Na+/K+-ATPase-α1表达恢复,缺氧/复氧诱导的凋亡减少。
  • 小鼠在体GM6001预处理可减轻肾缺血再灌注损伤,表现为细胞极性破坏和凋亡减轻。
  • 心脏术后患者血浆SDC-1在AKI组显著高于非AKI组,预测AKI的ROC曲线下面积为0.769。

适用人群与场景

  • 小鼠肾缺血再灌注模型;体外三维肾小管模型行缺氧/复氧;心脏手术后麻醉复苏时的患者(比较AKI与非AKI)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为基础实验(小鼠在体、体外三维肾小管模型)加临床观察性检测;样本量与中心数原文未提及。
  • 小鼠肾缺血再灌注后血清SDC-1脱落水平在再灌注12和24小时升高,伴Na+/K+-ATPase-α1表达下降、肾小管上皮细胞极性丧失和凋亡增加。
  • 体外三维肾小管模型缺氧/复氧后SDC-1脱落增加、Na+/K+-ATPase-α1表达下降,且随缺氧时间延长而加重。
  • GM6001抑制SDC-1脱落后,SDC-1和Na+/K+-ATPase-α1表达恢复,缺氧/复氧诱导的凋亡减少;小鼠GM6001预处理减轻缺血再灌注损伤(细胞极性破坏和凋亡减轻)。
  • 心脏术后患者血浆SDC-1在AKI组显著高于非AKI组,预测AKI的ROC曲线下面积为0.769。

证据类型、等级与局限

  • 证据类型:基础实验(小鼠在体、体外三维肾小管模型)加临床观察性检测;证据等级原文未提及。
  • 局限:临床部分为心脏术后单时间点血浆SDC-1检测,样本量与中心数原文未提及;GM6001为预处理给药,非治疗性给药;动物与体外结果需前瞻性验证。

对床旁实践的改变

  • 原文未提及

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

Syndecan-1 (SDC-1), a type of heparan sulfate proteoglycan on the surface of epithelial cells, is involved in maintaining cell morphology. Loss of cell polarity constitutes the early stage of ischemic acute kidney injury (AKI). This study investigated the role of SDC-1 shedding in I/R-induced AKI and the underlying mechanisms. Levels of the shed SDC-1 in the serum were measured with ELISA 12 and 24 h after reperfusion in renal I/R model mice. Na+/K+-ATPase-α1 expression was evaluated using western blotting in vivo and immunofluorescence in hypoxia/reoxygenation (H/R) cysts. Renal tubular epithelial cell apoptosis was measured using TUNEL in vivo and flow cytometry in vitro. Furthermore, plasma syndecan-1 (pSDC-1) levels were measured in patients at the time of anesthesia resuscitation after cardiac surgery. We found that shed SDC-1 levels increased and Na+/K+-ATPase-α1 expression decreased after H/R in the three-dimensional (3D) tubular model, and this state was exacerbated with extended period of hypoxia. After the inhibition of SDC-1 shedding by GM6001, SDC-1 and Na+/K+-ATPase-α1 expression was restored, while H/R-induced apoptosis was decreased. In vivo, SDC-1 shedding was induced by renal I/R and was accompanied with a loss of renal tubular epithelial cell polarity and increased apoptosis. GM6001 pretreatment protected against I/R injury by alleviating the disruption of cell polarity and apoptosis. pSDC-1 levels were significantly higher in AKI patients than in non-AKI patients. ROC curve showed that the accuracy of pSDC-1 for AKI prediction was 0.769. In conclusion, inhibition of I/R-induced SDC-1 shedding could contribute to renal protection by restoring the loss of cell polarity and alleviating apoptosis in tubular epithelial cells.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Guo M, Xu J, Zhao S, et al. Suppressing Syndecan-1 Shedding to Protect Against Renal Ischemia/Reperfusion Injury by Maintaining Polarity of Tubular Epithelial Cells. Shock. 2022. PMID: 34313252. doi:10.1097/SHK.0000000000001838

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。